Epstein Robert S
- SEC CIK
- 0001252004
In the past year, 2 open-market sale filings worth $1.19M and no purchases.
Current role at each company
- VCYT Veracyte, Inc.Directoras of Jun 15, 2026
- FATE Fate Therapeutics IncDirectoras of Jun 15, 2026
- ILMN Illumina, Inc.Directoras of May 23, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.19M
- 2 filings
- Net
- −$1.19M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Epstein Robert S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VCYT Veracyte, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2026 (view filing) | May 20 | 2 days | Epstein Robert SDirector | SSale | −10.0K | $44.01 | −$440.1K | −16.0%52.4K after | 10b5-1 |
| Oct 3, 2025 (view filing) | Oct 1 | 2 days | Epstein Robert SDirector | SSale | −21.5K | $35.08 | −$753.3K | −25.6%62.4K after | 10b5-1 |
| Nov 14, 2024 (view filing) | Nov 12 | 2 days | Epstein Robert SDirector | SSale | −15.0K | $38.32 | −$574.8K | −25.2%44.6K after | 10b5-1 |